Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

BACKGROUND AND AIM: This study aimed to elucidate whether interferon (IFN)-free direct-acting antiviral (DAA) therapy for hepatitis C after curative treatment of hepatocellular carcinoma (HCC) promotes HCC recurrence in a real-world large-scale cohort. METHODS: This multicenter study was conducted b...

Descripción completa

Detalles Bibliográficos
Autores principales: Mashiba, Toshie, Joko, Kouji, Kurosaki, Masayuki, Ochi, Hironori, Osaki, Yukio, Kojima, Yuji, Nakata, Ryo, Goto, Tohru, Takehiro, Akahane, Kimura, Hiroyuki, Mitsuda, Akeri, Kawanami, Chiharu, Uchida, Yasushi, Ogawa, Chikara, Kusakabe, Atsunori, Narita, Ryuichi, Ide, Yasushi, Abe, Takehiko, Tsuji, Keiji, Kitamura, Tadashi, Okada, Kazuhiko, Sohda, Tetsuro, Shigeno, Masaya, Satou, Takashi, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901785/
https://www.ncbi.nlm.nih.gov/pubmed/29659591
http://dx.doi.org/10.1371/journal.pone.0194704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901785/
https://www.ncbi.nlm.nih.gov/pubmed/29659591
http://dx.doi.org/10.1371/journal.pone.0194704

Ejemplares similares